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Abstract
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United States. Recent studies
suggest that pericardial adipose tissue (PCAT) secretes inflammatory factors that contribute to the development of CVD. To
better characterize the role of PCAT in the pathogenesis of disease, we performed a large-scale unbiased analysis of the
transcriptional differences between PCAT and subcutaneous adipose tissue, analysing 53 microarrays across 19 individuals.
As it was unknown whether PCAT-secreted factors are produced by adipocytes or cells in the supporting stromal fraction,
we also sought to identify differentially expressed genes in isolated pericardial adipocytes vs. isolated subcutaneous
adipocytes. Using microarray analysis, we found that: 1) pericardial adipose tissue and isolated pericardial adipocytes both
overexpress atherosclerosis-promoting chemokines and 2) pericardial and subcutaneous fat depots, as well as isolated
pericardial adipocytes and subcutaneous adipocytes, express specific patterns of homeobox genes. In contrast, a core set of
lipid processing genes showed no significant overlap with differentially expressed transcripts. These depot-specific
homeobox signatures and transcriptional profiles strongly suggest different functional roles for the pericardial and
subcutaneous adipose depots. Further characterization of these inter-depot differences should be a research priority.
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Introduction
Cardiovascular disease (CVD) has long been the leading cause
of death in the U.S. and the developed world [1]. While efforts to
decrease the impact of the major cardiovascular risk factors have
yielded modest success, there are indications that CVD mortality
rates may rise again because of the epidemic of obesity and
obesity-related comorbidities such as diabetes, hypercholesterol-
emia, and hypertension [2][3][4].
The relationship between adipose tissue and disease remains a
very active area of study, and efforts have further intensified since
the discovery that adipose tissue is an active, multifunctional
endocrine organ [5][6]. In part because of the strong correlation
between the size of the visceral adipose tissue (VAT) depot and the
incidence of CVD, type 2 diabetes mellitus, and metabolic
syndrome, attention has focused on understanding the molecular
and functional differences between VAT and subcutaneous
adipose tissue (SQAT) [7][8][9]. Compared to SQAT, human
VAT secretes more interleukin-6 (IL-6), expresses more peroxi-
some proliferator-activated receptor gamma (PPARc), and
produces less adiponectin [10][11][12]. With regards to CVD,
IL-6 has been particularly interesting because of its close
association to inflammation, obesity, and coronary heart disease
[13]. It is also a strong, independent marker for increased
mortality in the setting of CAD [14].
Given the depot-specific functions seen in VAT and SQAT, we
hypothesized that pericardial adipose tissue (PCAT) may play a
distinct physiologic role. Anatomically, PCAT lies between the
visceral and parietal pericardium and is therefore distinct from
epicardial adipose tissue (EAT) [15]. Using data from the
Framingham Heart Study, radiographic studies positively corre-
lated PCAT volume with the incidence of coronary artery
calcification, as well as the elevation of several metabolic risk
factors [16][17]. Similar results were found using data from several
other patient populations [18][19][20][21]. These studies, while
well-designed, provide neither transcriptional nor protein-level
insight into the physiology of PCAT. To our knowledge, we are
unaware of any studies that did so. In contrast, EAT has been
shown to both overexpress and oversecrete inflammatory markers
[22][23][24][25].
Given the absence of non-radiographic data regarding the
physiology of PCAT, we designed our study to identify
transcriptional differences between PCAT and SQAT, and also
between isolated pericardial adipocytes (pcAds) and isolated
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26092subcutaneous adipocytes (sqAds). Our study revealed that these
depots express specific patterns of homeobox genes. We further
found that PCAT and pcAds both overexpress atherosclerosis-
promoting chemokines. These depot-specific homeobox signatures
and transcriptional profiles strongly suggest different functional
roles for the pericardial and subcutaneous adipose depots.
Results
Between June 2009 and March 2010, 19 patients undergoing
elective cardiac operations at Massachusetts General Hospital
were enrolled in this study. From these patients, RNA samples
were isolated from SQAT, PCAT, sqAds, and pcAds, of which 53
samples (11 SQAT, 11 PCAT, 15 sqAds, and 16 pcAds) passed
quality standards for hybridization to Affymetrix U133A Plus 2.0
microarrays. Using nuclear and lipid stains, we determined that
our isolated adipocytes contained 96.7% single-nuclei adipocytes
(Fig. S1).
As our primary aim was the identification of depot-specific
transcription patterns, we first performed unbiased hierarchical
clustering of whole tissue and isolated adipocytes. This showed
clustering of samples which were processed in one specific month,
suggesting a strong batch effect (Fig. S2). To remove this effect,
principal component analysis was performed. After correction for
batcheffectsin processing(seeMethods)clusteringanalysisrevealed 3
distinctclusters.One cluster was composed solely of pcAds samples, a
second cluster contained 10 samples of which 9 were pcAds, and a
third cluster of 12 samples contained 9 pcAds samples (Fig. 1B).
We then used linear models to identify differentially expressed
genes between populations PCAT and SQAT, and between pcAds
and sqAds. Given the multiple hypothesis testing burden of
microarray analyses, a nominal p-value of 0.05 almost certainly
includes a large number of false positives. We thus restricted our
analysis to those genes that were differentially at a false-discovery
rate (FDR) of ,0.25 (Fig. 1C, Methods). In PCAT vs. SQAT, this
approach identified 2,284 differentially expressed probesets
(Fig. 1C). In pcAds vs. sqAds, this analysis yielded 657 differen-
tially expressed probesets.
To characterize the differentially expressed transcripts, we used
unbiased gene enrichment analysis (GEA) to look for enriched
Gene Ontology (GO) terms in the candidate probesets overex-
pressed in PCAT, SQAT pcAds and sqAds individually. Since
multiple probesets map to the same genes, a list of unique candi-
date genes were generated from probeset lists. These candidate
genes were ranked in order of greatest fold-change and analyzed
for GO category enrichment as ordered lists using FuncAssociate
2.0. [26].
Our GEA revealed that the four tissue types were each enriched
for multiple gene ontology categories (Table 1 and Table S1).
Because we analyzed both whole tissue and isolated adipocytes, we
were also able to infer whether the differentially expressed genes
arise from predominantly either the adipocytes themselves, or
from the more heterogeneous adipose tissue mixtures.
In sqAds, our GEA revealed a striking enrichment of pattern
specification genes (Table 1). Because the current GO classifica-
tions do not include all known homeobox genes, we manually
referenced our differentially expressed genes against a compre-
hensive list of human homeobox genes [27]. Compared to pcAds,
sqAds demonstrated increased expression of 12 homeobox genes,
including PAX3, HOXA10, HOXA9, and HOXB7 (Table 1). All
of the homeobox genes that were relatively higher in sqAds were
also increased in SQAT vs. PCAT (Table S2). For example, PAX3
was 3.3-fold (p=0.00002) increased in sqAds vs. pcAds and 3.8-
fold (p=0.0004) increased in SQAT vs. PCAT.
When we looked at homeobox expression in the pericardial
depot, we found significantly increased expression of two
homeobox genes, HOXA2 (2.53-fold, p=0.00012) and SATB1
(1.84-fold, p=0.015), in both pcAds and PCAT (Table 1 and
Table S2). In aggregate, the observed transcriptional patterns of
these 14 homeobox genes constitute depot-specific signatures.
GEA also found that our pcAds were significantly enriched for
immune response genes (p-adj,0.001, Table 1 and Table S3), with
26 immune response genes found among the top 2500 genes. A
similar result was seen in PCAT (p-adj=0.005, Table S1). These
genes included 7 chemokines, such as chemokine (C-C motif) ligand
4 (CCL4) which was overexpressed 2.79-fold (p,0.0001) in pcAds
and 2.9-fold (p=0.0009) in PCAT. To better visualize the
molecular relationships between these inflammatory genes, we
mapped the overexpressed genes to KEGG pathways (Fig. 2),
revealing that the chemokines upregulated in pcAds belong to the
tumor necrosis factor (TNF), CXC and CC chemokines, and IL-1
families. Since expression levels were not significantly lower in
pcAds compared to PCAT, it is possible that pericardial adipocytes
are a primary site for the synthesis of inflammatory mediators. We
thus sought to determine, using qPCR, the expression of CCL4 in
isolated pcAds and isolated pericardial stromal vascular fraction
(SVF). We found 12.5-fold (p=0.005) higher expression of CCL4 in
the pericardial SVF vs. the pcAds fraction. Altogether, these data
demonstrate that pcAds express inflammatory mediators but not to
the same degree as the SVF, which contains immune and inflam-
matory cells. In contrast to PCAT, our GEA revealed that SQAT
was significantly enriched in many metabolism-related GO cate-
gories (Table S1), including oxidoreductase activity (p-adj=0.002)
and lipid metabolic processes (p-adj=0.008). KEGG pathway-
mapping did not identify any recognized, adipose-tissue specific
pathways.
To validate the differential gene expression patterns identified
by our microarray analysis, we performed qPCR analysis on
patient-matched sqAds and pcAds samples (Fig. 3). For this
analysis, we selected homeobox genes HOXA9 and HOXB7; and
the adipocyte identity gene leptin. For all three genes, the
expression trend matched our microarray results.
Lastly, we confirmed that a core set of adipocyte identity and
function genes was not differentially expressed in pcAds vs. sqAds
(Table S4). The genes we selected included the well-studied
adipocyte identity maintenance factors perilipin (PLIN1) and cell
death-inducing DFFA-like effector c (CIDEC); the transcription
factors Peroxisome proliferator-activated receptor gamma
(PPARc) and the CCAAT/enhancer binding proteins (CEBPA,
CEBPB, CEBPD); the lipid catabolism enzymes lipoprotein lipase
(LPL) and hormone-sensitive lipase (LIPE); the adipocyte anabolic
enzymes fatty acid binding protein 4 (FABP4) and diacylglycerol
O-acyltransferase 1 (DGAT1); and the adipokines leptin (LEP),
adipsin (CFD), and adiponectin (ADIPOQ). We also considered
the brown fat identity gene uncoupling protein 1 (UCP1) and
found #0.50 fold change between the sample classes.
Discussion
Adipose tissue is an active, multifunctional organ whose
different depots in the human body most likely serve different
functions. For example, a strong correlation exists between excess
omental adipose tissue and the development of cardiovascular
disease [7][8][9]. While early evidence suggested that pericardial
adipose tissue functions in pericardial inflammation, these studies
were purely radiographic in nature [16][17][18][19][20][21].
There is evidence, however, that PCAT can directly affect cardiac
function as there is a several studies have found an association
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also serve an endocrine role, as increased PCAT volume is
positively associated with liver fat and insulin sensitivity after diet-
induced weight loss [30].
Our study is the first transcriptional microarray analysis of gene
expression differences between PCAT and SQAT and, importantly,
between pcAds and sqAds. We found that: 1) pericardial and sub-
cutaneous fat depots, as well as isolated pericardial and subcutaneous
adipocytes, express unique patterns of homeobox genes, and 2)
pericardial adipose tissue and isolated pericardial adipocytes both
overexpress chemokines that promote atherosclerosis. In contrast,
subcutaneous adiposetissue is enriched for metabolism-related genes.
The finding of a specific pericardial-specific homeobox
signature fits with recent reports of depot-dependent homeobox
signatures in humans. Gesta et al. compared human SQAT to
visceral adipose tissue (VAT) and found that SQAT overexpressed
SHOX2, HOXC9, EN1, and GPC4, while VAT overexpressed
factors including HOXA5, TBX15, and HOXC8 [31]. Our data
confirm that SHOX2 and HOXC9 are upregulated in SQAT
(Table 2). Vohl et al. reported that HOXA10 and HOXC6 were
upregulated in human SQAT vs. VAT; [32] this pattern is also
confirmed by our data (Table 1).
The functional importance of these signatures needs further
study. One hypothesis is that these homeobox signatures reflect
distinct cell lineages [33][34]. If so, such lineage differences, if
extensive, may imply that excess adiposity of different fat depots
(e.g. excess omental fat vs. excess pericardial fat) would not
respond equally well to single therapies. Rather than simply being
Figure 1. Experimental overview and clustering results. (A) Experimental design. (B) Clustering of isolated pericardial and subcutaneous
adipocytes following removal of date-related batch effects by principal component analysis. (C) In our unbiased GEA, differentially expressed genes in
each sample group (SQAT, sqAds, pcAds, and PCAT) were identified by preprocessing the data, performing principal component analysis, and setting
thresholds of p-value,0.05 and FDR ,0.25. Unique genes corresponding to candidate probesets were analyzed with FuncAssociate 2.0 (see
Methods).
doi:10.1371/journal.pone.0026092.g001
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# of Genes P-adjusted GO ID GO Category
Upregulated in sqAds
6 0.004 GO:0009952 anterior/posterior pattern formation
6 0.026 GO:0003002 regionalization
6 0.03 GO:0051262 protein tetramerization
8 0.047 GO:0051260 protein homooligomerization
10 0.006 GO:0043565 sequence-specific DNA binding
12 0.003 GO:0003700 transcription factor activity
19 0.02 GO:0009653 anatomical structure morphogenesis
48 0.002 GO:0032502 developmental process
Upregulated in pcAds
27 0 GO:0048583 regulation of response to stimulus
38 0 GO:0042127 regulation of cell proliferation
39 0 GO:0002376 immune system process
62 0 GO:0048522 positive regulation of cellular process
67 0 GO:0048518 positive regulation of biological process
15 0.001 GO:0050865 regulation of cell activation
24 0.001 GO:0008284 positive regulation of cell proliferation
26 0.001 GO:0006955 immune response
14 0.005 GO:0006935 chemotaxis
14 0.005 GO:0042330 taxis
24 0.01 GO:0009605 response to external stimulus
27 0.013 GO:0005576 extracellular region
32 0.014 GO:0035466 regulation of signaling pathway
5 0.02 GO:0042692 muscle cell differentiation
11 0.023 GO:0009897 external side of plasma membrane
26 0.026 GO:0051239 regulation of multicellular organismal process
44 0.038 GO:0042221 response to chemical stimulus
11 0.04 GO:0046649 lymphocyte activation
13 0.042 GO:0001775 cell activation
21 0.044 GO:0002682 regulation of immune system process
doi:10.1371/journal.pone.0026092.t001
Figure 2. Chemokines overexpressed in pcAds. Red boxes represent overexpressed molecules. Double-gray lines indicate cell surface
membrane; boxed proteins overlying double-gray lines are receptors.
doi:10.1371/journal.pone.0026092.g002
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function. Dankel et al. reported that profound fat loss in humans
was correlated with strong upregulation in SQAT of HOXA9,
HOXC6, and several other homeobox genes [35]. These genes
could represent novel targets for modifying adipogenesis and, by
extension, obesity.
The heterogeneous nature of different adipose depots is
highlighted by the functional differences in this study. Our data
show that both pericardial adipose tissue and isolated pericardial
adipocytes are immunologically active, overexpressing several
chemokines (Fig. 2), many of which have been implicated in the
development of atherosclerosis and coronary artery disease (CAD).
The CC subfamily chemokines overexpressed in our pcAds
(CCL4, and CCL5) are found at high levels in atherosclerotic
lesions [36][37][38][39][40]. CCL5 has been indirectly shown to
be atherogenic: antagonism of its receptor with a methionine-
retaining CCL5 isoform slows atherosclerosis in vivo [41]. Although
it was not included in Fig. 2, CCL2 also trended towards
overexpression in pcAds (1.5-fold overexpression, p-value=0.017)
but had an FDR of 0.26. When CCL2, also known as monocyte
chemoattractant protein-1 (MCP-1), was deleted in transgenic
mice, macrophages were not recruited into atherosclerotic plaques
and the atherosclerotic lesions were 60–70% smaller [42]. A
similar phenotype was observed in mice deficient for CCR2, the
receptor for CCL2 [43].
The overexpressed CXC subfamily chemokines also have
direct, pro-atherosclerotic effects in vivo [44]. CXCL1 was
implicated in the transition of early fatty streaks to intermediate
atherosclerotic lesions [45]. In porcine models it induced
endothelial dysfunction by downregulating nitric oxide synthase
protein levels [46]. CXCL5 appears to elevate serum levels of
CXCL1 and may be an indirect factor in atherogenesis [47].
In the interleukin family, IL-1b (1.7-fold overexpressed in
pcAds) is known to increase LDL binding to atherosclerotic lesions
which then induces more IL-1 production [48][49]. Conversely,
atherosclerosis-prone mice that were deficient in IL-1b had
significantly smaller atherosclerotic plaques [50]. Given this
mechanistic data, the overexpression of these chemokines in
Figure 3. Quantitative PCR confirms differential expression of homeobox genes HOXA9 and HOXB7; and adipocyte-identity gene
leptin (LEP) in patient-matched, isolated subcutaneous and pericardial adipocytes. Fold change patterns fit those seen in the microarray
data. The error bars reflect the effect of a unit increase or decrease in standard deviation of the delta Ct value on the fold-change. P-values were
calculated using 2-tailed heteroscedastic Student’s t-tests.
doi:10.1371/journal.pone.0026092.g003
Table 2. Upregulated Homeobox Genes in isolated
adipocytes from the pericardial and subcutaneous depots.
Overexpressed in pericardial adipocytes
Gene p-value q-value Fold Change
HOXA2 0.00012 0.0471 2.53
SATB1 0.01486 0.2493 1.84
Overexpressed in subcutaneous adipocytes
Gene p-value q-value Fold Change
PAX3 0.00002 0.0304 3.30
IRX5 0.00002 0.0304 2.97
EMX2 0.00003 0.0337 2.65
HOXC9 0.00007 0.0405 2.56
HOXA10 0.00004 0.0337 2.50
IRX3 0.00031 0.0747 2.49
IRX1 0.00069 0.0967 2.48
HOXB7 0.00013 0.0475 2.45
HOXA9 0.00011 0.0471 2.39
HOXC6 0.00109 0.1171 2.30
SHOX2 0.02595 0.2920 1.97
HOXC10 0.01495 0.2493 1.79
doi:10.1371/journal.pone.0026092.t002
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the development of coronary artery atherosclerosis.
Our study highlights a number of new areas for further
research. It is unclear if these depot-specific homeobox gene
signatures are residual from differentiation, or continue to drive
expression of genes important for defining tissue identity.
Compelling follow-up studies would include identification of
downstream targets and pathways of these homeobox genes.
More research is also needed to confirm local and perhaps
systemic levels of pericardial adipocyte-secreted chemokines, and
further on, to identify the pathways that they activate.
In conclusion, pericardial and subcutaneous fat depots express
unique homeobox signatures and serve very different functional
roles. As the first microarray study of the pericardial adipose
depot, we show that pericardial adipocytes preferentially express
pro-atherosclerotic factors and may therefore function in the
development of cardiovascular disease. Future research should aim
to further characterize these emerging, depot-specific functions.
Materials and Methods
This Project has been reviewed and approved by the Brigham &
Women’s Hospital Institutional Review Board, Assurance #
FWA00000484. During the review of this Project, the IRB
specifically considered (i) the risks and anticipated benefits, if any,
to subjects; (ii) the selection of subjects; (iii) the procedures for
securing and documenting informed consent; (iv) the safety of
subjects; and (v) the privacy of subjects and confidentiality of the
data. Written consent was obtained from all participants.
Between June 2009 and April 2010, 21 patients who underwent
elective coronary artery bypass grafting and/or cardiac valve
replacement surgeries participated in the study. With the
exception of prisoners and subjects with surrogate decision makers,
there were no exclusion criteria or patient classes. No enrolled
patients were excluded. Approximately 5 mL of pericardial
adipose tissue (PCAT) and 3 mL of subcutaneous adipose tissue
(SQAT) from the anterior chest wall were harvested from patients
undergoing elective coronary artery bypass grafting and/or
cardiac valve replacement surgery. Epicardial adipose tissue was
not harvested. As adipose degrades quickly after surgical removal,
all samples were retrieved immediately from the operating room
after being harvested. The samples were sectioned and assigned to
either whole tissue analysis or isolated adipocyte analysis. For
PCAT and SQAT samples, RNA was immediately extracted via
submersion in 1 ml of Trizol, mechanical lysis using an RNase free
pestle (Kimble Chase Kontes), addition of 200 ml chloroform, and
centrifugation (10,000 g, 15 minutes, 4C). The supernatant was
extracted and purified with RNeasy Mini Columns (Qiagen).
1.2 mg RNA was synthesized into complementary DNA (cDNA)
with the Superscript III First Strand Synthesis Kit (Invitrogen).
For adipocyte isolation, tissue samples were minced and
digested in Liberase Blendzyme (0.625 g dissolved in 50 mL
PBS) for one hour at 37C, in a rotating incubator. Following
digestion, Blendzyme was inactivated via the addition of KRB
solution (bovine serum albumin, Hank’s balanced salt solution,
PBS, and gentamicin). The samples were filtered through a 200
micron steel mesh filter and centrifuged at 1000 rpm for
5 minutes. Single adipocytes were collected from the uppermost
fraction and immediately frozen in liquid nitrogen. RNA was then
extracted from the sqAds and pcAds samples in the same fashion
as SQAT/PCAT samples. To quantify the purity of the isolated
adipocytes, 150 uL of freshly isolated adipocytes was mixed with
150 uL of PBS containing Hoescht 33258 nuclear stain (Invitro-
gen, 10 mg/mL, diluted 1:5000) and Bodipy stain (Invitrogen,
5 mM diluted 1:20,000). 50 uL of this mix was mounted directly
onto slides (Fischer) using Aqua Poly/Mount (Polysciences). Cells
and nuclei were counted using a Nikon Eclipse Ti microscope, and
representative images were captured using NIS-Elements software
package (Nikon, version 3.10).
All RNA samples were analyzed for quality using an Agilent
2100 Bioanalyzer. Suitable samples were hybridized to Affymetrix
Human Genome U133 Plus 2.0 Arrays. The arrays were
processed by the Stowers Institute for Medical Research Bioinfor-
matics Core Facility. All data is MIAME compliant and the raw
data has been deposited in the Gene Expression Omnibus
database (accession number GSE26339).
Raw expression values were analyzed with GenePattern 2.0
[51]. Data were normalized using Robust Multiarray Averaging
(RMA) with median scaling, quintile normalization, and back-
ground correction. The resulting datasets were preprocessed to
remove probesets whose minimum fold change (maximum gene
expression value divided by the minimum value) was ,2, or whose
difference between maximum and minimum values was less than
100. The preprocessed data was clustered in an unbiased
hierarchical fashion, with Pearson correlation and pairwise
complete-linkage.
RNA samples were collected, extracted, amplified and hybrid-
ized in several separate batches over the period of 10 months. To
explore the influence of batch effects, principal component
analysis was performed using the prcomp function in R (2.9.1).
The first principal component, explaining 38% of the variance,
corresponded to the date of sample processing, with samples
processed in June 2009 grouped separately from all other samples.
The contribution of this component was removed from normal-
ized intensities prior to further analysis.
Unbiased GEA was performed using FuncAssociate 2.0 (http://
llama.mshri.on.ca/funcassociate/), which uses a Fisher’s exact test
to assess enrichment and a resampling approach to correct for
multiple hypotheses. For each of the sample populations, a false
discovery rate (FDR) of 0.25 was set as the threshold. We also
performed sensitivity analysis to ensure that FDR thresholds
between 0.2 and 0.3 did not change the identify of enriched gene
sets. The differentially expressed probesets were uploaded into
FuncAssociate 2.0 as ordered lists. Analysis was performed using
the hgnc_symbol namespace, with 1000 permutations for p-value
estimation and a p-value cutoff of 0.05.
Pathways involving upregulated genes in significantly enriched
GO categories were identified using DAVID and KEGG
[52][53][54].
For qPCR, expression levels of HOXA9 and HOXB7 were
normalized to the housekeeping gene beta-2-microglobulin (B2M)
and measured via Taqman Assay (Applied Biosciences). Both the
pcAds and sqAds samples were patient-matched (Patient 15).
Leptin expression levels in matched samples (from Patient 5) were
normalized to hypoxanthine-guanine phosphoribosyltransferase
(HPRT) and measured via Quantifast SYBR Green PCR Kit
(Qiagen). To minimize the potential impact of any genomic DNA
contamination, all primers were designed and verified to span
multiple exons. Three technical replicates were performed for
each sample. Error bars were computed by adding and subtracting
1 unit standard deviation of the delta Ct values from calibrated
delta Ct values. P-values were calculated in Microsoft Excel 2007
using 2-tailed heteroscedastic Student’s t-tests.
Supporting Information
Figure S1 Purity of isolated adipocytes. (A) Results of nuclear
and cell counts in isolated adipocyte fraction; the fraction is 96.7%
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1:1 association of nuclei with adipocytes.
(TIF)
Figure S2 Unbiased hierarchical clustering of isolated pericar-
dial adipocytes (pcAds) and isolated subcutaneous adipocytes
(sqAds). Sections of the dendrogram in red indicate samples
clustering of pcAds and sqAds samples processed in June 2009.
(TIF)
Table S1 Enriched Gene Ontology categories in SQAT and
PCAT.
(DOCX)
Table S2 Upregulated Homeobox Genes in SQAT and PCAT.
(DOCX)
Table S3 Upregulated Immune Response genes in pericardial
adipocytes.
(DOCX)
Table S4 Expression of core adipocyte function genes in isolated
pericardial adipocytes (pcAds) vs. isolated subcutaneous adipocytes
(sqAds).
(DOCX)
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